Today there are an increasing number of medications for glaucoma. But as yet we are still in the Dark Ages insofar as the cause of this visually disabling disorder.
See the best of our print edition with the 2024 cover story roundup
Our top 10 print stories highlight the core content concepts we explored this year
Ethnic background has an impact on glaucoma outcomes
Gauging patient perceptions in an ethnically diverse UK cohort
New study examines RNFL changes and association with BMI, tobacco and alcohol use
A higher body mass index was protective against glaucoma progression, while patients who were underweight had significantly faster rates of structural loss
Playing matchmaker with Schlemm canal surgery
Two glaucoma specialists discuss pairing patients with the right procedures
Glaucoma specialists take back treatment compliance
Moving on from medication “stacks” and the old-school reactive approach
Six-year findings from laser in glaucoma and ocular hypertension (LiGHT)
In visual field progression results, SLT was superior to ocular drops as first-line treatment for patients with glaucoma